Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Influenza specialty page provides influenza-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Gamma Delta Cells Potentially Play a Critical Role in Protecting Infants From Influenza Complications
A new study by St. Jude Children’s Research Hospital reported that gamma delta (γδ) T cells play a key role in protecting infants from flu complications.
Universal Influenza Vaccine Candidate Produces Strong Responses in Animal Models
A universal flu vaccine candidate elicits protective response in mice against multiple strains of the virus.
Innate Immune System Prioritizes Lung Infections Over Wound Healing
In a wounded mouse model concurrently infected with influenza A, investigators observed that the innate immune system prioritized responding to the lung infection, delaying wound healing.
2018-2019 Flu Vaccine Recommendations from ACIP
New recommendations from the CDC's Advisory Committee on Immunization Practices reveal that health care providers have the intranasally-administered live attenuated influenza vaccine (LAIV) among their arsenal of available vaccines for the 2018-2019 flu season.
Obesity Could Extend Duration of Influenza A Viral Shedding
Investigators report that the duration of viral shedding of influenza A in obese adults was 42% longer than nonobese adults.
New Influenza Antiviral Performs Well in Human Challenge for Phase 1 Trial
With vaccine efficacy during the 2017–2018 flu season under question, a novel antiviral agent may provide a solution.
PrEP Use May Result in Increased Receipt of Non-HIV-Related Primary Care
A new study reports that PrEP users were more likely to receive more primary health care services compared with non-PrEP users.
Oral, Single-Dose Antiviral Significantly Reduces Symptoms In High-Risk Influenza Patients
Genentech has announced that baloxavir marboxil met primary objective in the phase 3 CAPSTONE-2 study for individuals with a high risk of complications from influenza. 
Big advances in treatment can